PBH Prestige Consumer Healthcare Inc. Common Stock
NYSE · Pharmaceuticals · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 6, 2026
$45,26
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$42,62Bas 52 semaines
$71,07Haut 52 semaines
Capitalisation Boursière (MRQ)
$2.55B
P/E (TTM)
12.7
BPA (TTM)
$3.57
Revenu (TTM)
$1.10B
vos badges
Fourchette 52 semaines
$43–$71
Note des analystes
BUY
Objectif de cours
$68
P/E
12.7
ROE
9.1%
Marge nette
15.6%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
PBH Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$45.26
Capitalisation Boursière (MRQ)
$2.55B
P/E (TTM)
12.7
BPA (TTM)
$3.57
Revenu (TTM)
$1.10B
ROE (TTM)
9.1%
Dette/Capitaux propres (MRQ)
1.1
Fourchette 52 semaines
$43–$71
PBH Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
À propos de Prestige Consumer Healthcare Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
Source : Wikipedia (Anglais), CC BY-SA 4.0 · Voir sur Wikipedia ↗
secteurHealthcare
industriePharmaceuticals
employés890
paysUS
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$1.09B2017-03-31 → 2026-03-31
BPA$3.912017-03-31 → 2026-03-31
Flux de trésorerie libre$246M2017-03-31 → 2026-03-31
Marge nette15.6%2017-03-31 → 2026-03-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | PBH | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 12.7moyenne 5 ans ≈5.5 | ≈5.5 | · | · | |
| P/S (TTM) | 2.3moyenne 5 ans ≈3.3 | ≈3.3 | · | · | |
| P/B (MRQ) | 1.3moyenne 5 ans ≈2.2 | ≈2.2 | · | · | |
| Cours / FCF (TTM) | 10.8moyenne 5 ans ≈15.4 | ≈15.4 | · | · | |
| Cours / Flux de trésorerie (TTM) | 10.2moyenne 5 ans ≈14.9 | ≈14.9 | · | · | |
| Cours / Actif net tangible (MRQ) | -1.9 | · | · | · | |
| PEG Ratio (Ratio PEG) | ≈3.4 | · | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | PBH | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge Brute (TTM) | 53.5%moyenne 5 ans ≈55.7% | ≈55.7% | · | · | |
| Marge d'exploitation (TTM) | 26.3%moyenne 5 ans ≈23.4% | ≈23.4% | · | · | |
| Marge EBITDA (TTM) | 29.2%moyenne 5 ans ≈26.2% | ≈26.2% | · | · | |
| Pretax Margin (Marge avant impôts) | 23.6%moyenne 5 ans ≈17.8% | ≈17.8% | · | · | |
| Marge nette (TTM) | 15.6%moyenne 5 ans ≈13.3% | ≈13.3% | · | · | |
| ROA (TTM) | 4.3%moyenne 5 ans ≈4.3% | ≈4.3% | · | · | |
| ROE (TTM) | 9.1%moyenne 5 ans ≈8.6% | ≈8.6% | · | · | |
| ROIC | 12.1%moyenne 5 ans ≈8.6% | ≈8.6% | · | · |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | PBH | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Dette / Capitaux propres (MRQ) | 1.1moyenne 5 ans ≈0.8 | ≈0.8 | · | · | |
| Ratio de liquidité (MRQ) | 3.2moyenne 5 ans ≈3.1 | ≈3.1 | · | · | |
| Quick Ratio (Ratio de liquidité réduite) | 2.1moyenne 5 ans ≈1.9 | ≈1.9 | · | · | |
| Dette à long terme / Capitaux propres (MRQ) | 1.0moyenne 5 ans ≈0.8 | ≈0.8 | · | · |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | PBH | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | -4.3%moyenne 5 ans ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | -1.2%moyenne 5 ans ≈2.1% | ≈2.1% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 2.9% | · | · | · | |
| EPS YoY (BPA Année/Année) | -8.9%moyenne 5 ans ≈6.1% | ≈6.1% | · | · | |
| Net Income YoY (Bénéfice net YoY) | -11.3%moyenne 5 ans ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (TCAC BPA 3 ans) | 2.0% | · | · | · | |
| EPS CAGR 5Y (TCAC BPA 5 ans) | 3.8% | · | · | · | |
| Net Income CAGR 3Y (TCAC Bénéfice net 3 ans) | 1.5% | · | · | · | |
| Net Income CAGR 5Y (TCAC Bénéfice net 5 ans) | 2.9% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | PBH | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.3moyenne 5 ans ≈0.3 | ≈0.3 | · | · | |
| Inventory Turnover (Rotation des stocks) | 3.2moyenne 5 ans ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Rotation des créances) | 5.6moyenne 5 ans ≈6.8 | ≈6.8 | · | · | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$1.2M | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.02%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | $0.98 | $0.89 | 10.0% | |
| 31 mars 2026 | $1.23 | $1.40 | -12.4% | |
| 31 décembre 2025 | $1.14 | $1.16 | -1.4% | |
| 30 septembre 2025 | $1.07 | $0.98 | 9.2% | |
| 30 juin 2025 | $0.95 | $1.01 | -6.0% | |
| 31 mars 2025 | $1.32 | $1.31 | 0.64% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
Bilan
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
Flux de trésorerie
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
Rentabilité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
Liquidité et Solvabilité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
Efficacité
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
Par action
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $33.58 | $32.76 | $29.82 | $26.38 | $28.98 | $25.15 | $21.76 | $20.42 | $22.07 | $15.44 | $14.03 | $11.94 | |
| Revenue / Share | $22.35 | $22.72 | $22.43 | $22.60 | $21.38 | $18.64 | $18.83 | $18.74 | $19.45 | $16.53 | $15.17 | $13.55 | |
| Cash Flow / Share | $5.29 | $5.02 | $4.96 | $4.60 | $5.11 | $4.66 | $4.25 | $3.64 | $3.93 | $2.77 | $3.28 | $2.97 | |
| Cash / Share | $1.14 | $1.75 | $0.84 | $1.07 | $0.50 | $0.60 | $1.76 | $0.51 | $0.61 | $0.79 | $0.51 | $0.41 | |
| EPS (TTM) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 |
Taux de croissance
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
Compte de résultat
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | · | 47,880,000 | 49,025,000 | 49,475,000 | · | 49,597,000 | 49,652,000 | 49,886,000 | · | 49,740,000 | 49,687,000 | 49,767,000 | · | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | · | 48,087,000 | 49,264,000 | 49,833,000 | · | 49,993,000 | 49,998,000 | 50,267,000 | · | 50,125,000 | 50,081,000 | 50,196,000 | · | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
Bilan
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
Flux de trésorerie
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
Rentabilité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
Liquidité et Solvabilité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
Efficacité
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
Par action
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $34.04 | · | $32.55 | $32.48 | $33.03 | · | $31.97 | $31.05 | $30.17 | · | $28.93 | $27.78 | $26.81 | · | $30.75 | $29.62 | |
| Revenue / Share | $5.58 | · | $5.89 | $5.56 | $5.01 | · | $5.81 | $5.68 | $5.31 | · | $5.64 | $5.72 | $5.56 | · | $5.49 | $5.75 | |
| Cash Flow / Share | $1.49 | · | · | · | $1.59 | · | · | · | $1.09 | · | · | · | $0.96 | · | · | · | |
| Cash / Share | $1.58 | · | $1.11 | $2.12 | $2.48 | · | $0.91 | $0.92 | $0.61 | · | $1.15 | $1.09 | $0.99 | · | $1.57 | $0.78 | |
| EPS (TTM) | $3.57 | · | $3.78 | $4.03 | $4.26 | · | $4.27 | $4.11 | $4.09 | · | $-1.61 | $-1.63 | $-1.68 | · | $4.17 | $4.12 |
Valorisation (TTM)
| Métrique | Tendance | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.10B | · | $1.10B | $1.11B | $1.12B | · | $1.12B | $1.11B | $1.11B | · | $1.13B | $1.13B | $1.13B | · | $1.11B | $1.11B | |
| Net Income TTM | $172M | · | $187M | $201M | $213M | · | $214M | $206M | $205M | · | $-81M | $-82M | $-84M | · | $210M | $209M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.2 | · | 16.3 | 15.5 | 18.7 | · | 18.3 | 17.5 | 16.8 | · | -38.0 | -35.1 | -35.4 | · | 15.0 | 12.1 | |
| P/S | 2.4 | · | 3.1 | 3.2 | 4.0 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.5 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| EV / Revenue | 4.2 | · | · | · | · | · | 4.8 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.0 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.5% | · | 6.1% | 6.5% | 5.3% | · | 5.5% | 5.7% | 5.9% | · | -2.6% | -2.9% | -2.8% | · | 6.7% | 8.3% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Revenu | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| Marge Brute % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| Marge d'exploitation % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| Résultat net | $190M | $215M | $209M | $-82M | $205M |
| BPA dilué | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dette / Capitaux propres | · | · | 0.7 | 0.9 | 0.9 |
| Ratio de liquidité | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| Ratio de liquidité réduite | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
| Métrique | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $246M | $243M | $239M | $222M | $250M |
Détenteurs institutionnels (13F) 340 déclarants · $2.9B total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
340
Valeur détenue
$2.9B
Nouvelles positions
39
Positions clôturées
69
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 39 (-19 vs T. préc.) | 69 (+29 vs T. préc.) | 108 (-17 vs T. préc.) | 119 (-10 vs T. préc.) | +2.2M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $370 187 111 | 7 831 333 | 12,99% | Actions |
| VANGUARD GROUP INC | $332 432 481 | 5 388 758 | 11,66% | Actions |
| ARIEL INVESTMENTS, LLC | $230 143 970 | 4 868 711 | 8,07% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133 553 822 | 2 825 340 | 4,69% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $125 802 061 | 2 661 291 | 4,41% | Actions |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110 225 175 | 2 331 821 | 3,87% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $101 013 343 | 2 136 944 | 3,54% | Actions |
| STATE STREET CORP | $100 047 570 | 2 116 513 | 3,51% | Actions |
| BRANDES INVESTMENT PARTNERS, LP | $96 953 606 | 2 051 060 | 3,40% | Actions |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $88 490 528 | 1 872 023 | 3,10% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $74 306 032 | 1 571 742 | 2,61% | Actions |
| Allspring Global Investments Holdings, LLC | $61 257 112 | 1 271 950 | 2,15% | Actions |
| MORGAN STANLEY | $58 800 671 | 1 243 931 | 2,06% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $39 252 108 | 828 628 | 1,38% | Actions |
| NORTHERN TRUST CORP | $36 560 934 | 773 449 | 1,28% | Actions |
| WESTWOOD HOLDINGS GROUP INC | $35 473 535 | 750 445 | 1,24% | Actions |
| RICE HALL JAMES & ASSOCIATES, LLC | $32 601 741 | 689 692 | 1,14% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31 134 811 | 658 659 | 1,09% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30 922 805 | 654 174 | 1,08% | Actions |
| UBS Group AG | $30 186 858 | 638 605 | 1,06% | Actions |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29 772 348 | 629 836 | 1,04% | Actions |
| Boston Trust Walden Corp | $28 832 289 | 609 949 | 1,01% | Actions |
| GOLDMAN SACHS GROUP INC | $27 725 541 | 586 536 | 0,97% | Actions |
| CITADEL ADVISORS LLC | $26 667 701 | 564 157 | 0,94% | Actions |
| BANK OF AMERICA CORP /DE/ | $26 277 109 | 555 894 | 0,92% | Actions |
| RAYMOND JAMES FINANCIAL INC | $21 949 967 | 464 353 | 0,77% | Actions |
| Leeward Investments, LLC - MA | $20 700 289 | 437 916 | 0,73% | Actions |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19 921 578 | 421 440 | 0,70% | Actions |
| Invesco Ltd. | $19 209 111 | 406 370 | 0,67% | Actions |
| Woodline Partners LP | $17 004 012 | 359 721 | 0,60% | Actions |
| ARMISTICE CAPITAL, LLC | $15 882 720 | 336 000 | 0,56% | Actions |
| Glenmede Investment Management, LP | $15 685 425 | 251 369 | 0,55% | Actions |
| Bank of New York Mellon Corp | $15 375 752 | 325 275 | 0,54% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $14 837 438 | 313 887 | 0,52% | Actions |
| D. E. Shaw & Co., Inc. | $14 832 286 | 313 778 | 0,52% | Actions |
| WELLS FARGO & COMPANY/MN | $14 604 614 | 308 962 | 0,51% | Actions |
| Nuveen, LLC | $14 012 435 | 296 434 | 0,49% | Actions |
| Congress Wealth Management LLC / DE / | $13 030 320 | 163 185 | 0,46% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $12 700 693 | 268 684 | 0,45% | Actions |
| Tributary Capital Management, LLC | $11 958 554 | 252 984 | 0,42% | Actions |
| Fisher Asset Management, LLC | $11 698 136 | 247 474 | 0,41% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $11 013 816 | 232 998 | 0,39% | Actions |
| PRUDENTIAL FINANCIAL INC | $10 251 209 | 216 865 | 0,36% | Actions |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10 122 871 | 214 150 | 0,36% | Actions |
| JPMORGAN CHASE & CO | $10 050 950 | 207 249 | 0,35% | Actions |
| Aristotle Capital Boston, LLC | $10 043 458 | 212 470 | 0,35% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $9 983 703 | 211 206 | 0,35% | Actions |
| FMR LLC | $9 951 172 | 210 518 | 0,35% | Actions |
| GLENMEDE TRUST CO NA | $9 729 017 | 205 818 | 0,34% | Actions |
| JENNISON ASSOCIATES LLC | $9 393 259 | 198 715 | 0,33% | Actions |
Initiés de la société 50 initiés · 29 dirigeants · 18 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 7 mai 2026 F | 373 465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 1 juin 2015 M | 27 706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 3 mars 2009 P | 177 168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 mai 2006 P | 33 278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 2 mai 2026 F | 57 374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 9 mai 2016 A | 11 050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 mai 2010 D | 401 850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 mai 2026 S | 41 810 | 0 | 7 | $-246 374 |
| Adel Mekhail | EVP, Marketing & Sales | 7 mai 2026 F | 25 703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 4 mai 2026 A | 28 149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 6 janvier 2026 A | 3 436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 7 mai 2025 F | 17 051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 9 mai 2019 F | 21 717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 mai 2018 M | 11 081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 7 mai 2018 A | 8 150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 août 2017 F | 6 678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 mai 2017 F | 62 075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 mai 2016 M | 55 927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 mai 2016 M | 32 176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 mai 2014 M | 15 282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 mai 2011 F | 13 236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 mai 2010 D | 28 331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 mai 2010 D | 16 640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 mars 2009 D | 30 579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 mars 2009 D | 90 846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 mai 2008 A | 27 427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 2 janvier 2007 D | 289 172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 février 2005 S | 180 560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 février 2005 S | 72 347 | 0 | 0 | $0 |
| Sheila Hopkins | Administrateur | 5 août 2025 A | 30 123 | 0 | 0 | $0 |
| Natale S Ricciardi | Administrateur | 1 août 2023 A | 27 098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | Administrateur | 2 août 2022 A | 13 218 | 0 | 0 | $0 |
| James M Jenness | Administrateur | 4 août 2020 A | 22 791 | 0 | 0 | $0 |
| Carl J Johnson | Administrateur | 31 juillet 2018 A | 14 598 | 0 | 0 | $0 |
| Charles Hinkaty | Administrateur | 4 août 2015 A | 31 714 | 0 | 0 | $0 |
| Patrick Lonergan | Administrateur | 10 décembre 2012 G | 37 323 | 0 | 0 | $0 |
| John Byom | Administrateur | 3 août 2010 A | 29 755 | 0 | 0 | $0 |
| Vincent J Hemmer | Administrateur | 10 septembre 2009 J | 80 410 | 0 | 0 | $0 |
| Peter Mann | Administrateur | 4 août 2009 A | 447 700 | 0 | 0 | $0 |
| Dick L Buell | Administrateur | 4 août 2009 A | 27 662 | 0 | 0 | $0 |
| David Donnini | Administrateur | 29 mai 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | Administrateur | 5 août 2008 A | 30 352 | 0 | 0 | $0 |
| Raymond Silcock | Administrateur | 5 août 2008 A | 16 249 | 0 | 0 | $0 |
| John F. Kelly | · | 4 août 2026 A | 7 832 | 0 | 0 | $0 |
| James Darecca | · | 4 août 2026 A | 9 572 | 0 | 0 | $0 |
| Dawn M. Zier | · | 4 août 2026 A | 19 514 | 0 | 0 | $0 |
| Celeste A. Clark | · | 4 août 2026 A | 16 511 | 0 | 0 | $0 |
| John E Byom | · | 4 août 2026 A | 54 575 | 0 | 1 | $-178 050 |
| COSTLEY GARY E | · | 4 août 2020 A | 50 200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | · | 29 mai 2009 S | 0 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 67 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,86% | 347 516 SH | 1 octobre 2026 | Quotidien |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,17% | 45 519 SH | 1 octobre 2026 | Quotidien |
| PILL · Direxion Shares ETF Trust | 1,16% | 4 781 NS | 31 juillet 2026 | N-PORT |
| HSMV · First Trust Exchange-Traded Fund III | 0,80% | 5 597 NS | 31 juillet 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,65% | 25 280 NS | 31 juillet 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,59% | 201 NS | 31 juillet 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,52% | 3 105 NS | 31 juillet 2026 | N-PORT |
| IHE · iShares Trust | 0,51% | 175 342 SH | 11 septembre 2026 | Quotidien |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,34% | 92 272 NS | 31 juillet 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,25% | 181 211 NS | 31 juillet 2026 | N-PORT |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100 520 SH | 19 août 2026 | Quotidien |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 18 534 NS | 31 juillet 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41 965 SH | 19 août 2026 | Quotidien |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,15% | 7 601 SH | 1 octobre 2026 | Quotidien |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,13% | 4 372 NS | 31 juillet 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165 811 SH | 19 août 2026 | Quotidien |
| ROSC · Lattice Strategies Trust | 0,12% | 1 466 NS | 31 juillet 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,12% | 195 077 NS | 31 juillet 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 8 140 SH | 1 octobre 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 67 943 SH | 1 octobre 2026 | Quotidien |
| EBIT · Harbor ETF Trust | 0,11% | 258 NS | 31 juillet 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1 747 NS | 31 juillet 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,09% | 43 685 NS | 31 juillet 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 11 789 NS | 31 juillet 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7 246 SH | 19 août 2026 | Quotidien |
| RSSL · Global X Funds | 0,08% | 22 923 NS | 31 juillet 2026 | N-PORT |
| IWM · iShares Trust | 0,07% | 1 227 360 SH | 11 septembre 2026 | Quotidien |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175 325 SH | 19 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275 721 SH | 19 août 2026 | Quotidien |
| DFAT · Dimensional ETF Trust | 0,07% | 196 959 NS | 31 juillet 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28 729 SH | 1 octobre 2026 | Quotidien |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690 582 SH | 19 août 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,05% | 152 317 NS | 31 juillet 2026 | N-PORT |
| IGRO · iShares Trust | 0,05% | 10 967 SH | 11 septembre 2026 | Quotidien |
| WSML · iShares Trust | 0,04% | 5 420 SH | 11 septembre 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 22 700 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 544 134 SH | 19 août 2026 | Quotidien |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1 087 231 SH | 19 août 2026 | Quotidien |
| VHT · VANGUARD WORLD FUND | 0,03% | 142 413 SH | 19 août 2026 | Quotidien |
| DFAC · Dimensional ETF Trust | 0,01% | 117 382 NS | 31 juillet 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,01% | 36 640 NS | 31 juillet 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 5 233 NS | 31 juillet 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 688 472 SH | 19 août 2026 | Quotidien |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,01% | 453 610 SH | 19 août 2026 | Quotidien |
| VSGX · VANGUARD WORLD FUND | 0,01% | 9 203 SH | 19 août 2026 | Quotidien |
| IDEV · iShares Trust | 0,01% | 52 014 SH | 11 septembre 2026 | Quotidien |
| DXUV · Dimensional ETF Trust | 0,01% | 829 NS | 31 juillet 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 3 004 NS | 31 juillet 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4 442 NS | 31 juillet 2026 | N-PORT |
| IXUS · iShares Trust | 0,01% | 56 667 SH | 11 septembre 2026 | Quotidien |
| ITOT · iShares Trust | 0,00% | 69 137 SH | 11 septembre 2026 | Quotidien |
| IWV · iShares Trust | 0,00% | 14 019 SH | 11 septembre 2026 | Quotidien |
| DFAU · Dimensional ETF Trust | 0,00% | 6 651 NS | 31 juillet 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10 940 NS | 31 juillet 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 510 012 SH | 19 août 2026 | Quotidien |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 69 368 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 089 SH | 19 août 2026 | Quotidien |
| ESGV · VANGUARD WORLD FUND | 0,00% | 10 506 SH | 19 août 2026 | Quotidien |
| IJR · iShares Trust | · | 2 889 316 SH | 10 septembre 2026 | Quotidien |
| IJS · iShares Trust | · | 422 466 SH | 8 septembre 2026 | Quotidien |
| IWN · iShares Trust | · | 449 434 SH | 11 septembre 2026 | Quotidien |
| XJR · iShares Trust | · | 6 541 SH | 31 août 2026 | Quotidien |
| SVAL · iShares Trust | · | 10 792 SH | 3 septembre 2026 | Quotidien |
| ISCB · iShares Trust | · | 1 977 SH | 11 septembre 2026 | Quotidien |
| ISCV · iShares Trust | · | 9 565 SH | 11 septembre 2026 | Quotidien |
| SMLF · iShares Trust | · | 38 488 SH | 11 septembre 2026 | Quotidien |
| SMMV · iShares Trust | · | 20 132 SH | 25 août 2026 | Quotidien |
PBH Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 10 analystes
ACHAT
Objectif médian
$70.00
+54,7%
3 30,0%
Achat fort
4 40,0%
Achat
3 30,0%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
5 analystes · 2026-10-03Objectif moyen $67.80 +49,8%
← En dessous de tous les objectifs
Prix actuel $45.26
Bas$55.00
Moyenne$67.80
Haut$75.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 6, 2026